{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Grover Beach",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "82574",
      "recalling_firm": "H J Harkins Company Inc dba Pharma Pac",
      "address_1": "1400 W Grand Ave Ste F",
      "address_2": "N/A",
      "postal_code": "93433-4221",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed to a physician's office in California.",
      "recall_number": "D-1083-2019",
      "product_description": "Losartan Potassium 100 mg Tablets # 30  Losartan potassium tablets USP, 100 mg are white to off white, film coated, tear drop shaped tablets, debossed with \"H\"  on one side and \"145\" on the other side.",
      "product_quantity": "300 tablets",
      "reason_for_recall": "CGMP Deviations:Traces amounts of N-Nitroso N-Methyl 4- amino butyric acid (NMBA) impurity found in Active Pharmaceutical Ingredient (API).",
      "recall_initiation_date": "20190304",
      "center_classification_date": "20190407",
      "termination_date": "20230524",
      "report_date": "20190417",
      "code_info": "Pharma Pac NDC: 76519-1033-03, Pharma Pac Lot # LTO00EW, Exp. 11/19, MFG NDC 31722-0702-30, MFG Lot # LOP17087, Exp. 11/2019."
    }
  ]
}